Search Results - "Silva, Lais Teodoro da"

  • Showing 1 - 14 results of 14
Refine Results
  1. 1

    Using Dendritic Cell-Based Immunotherapy to Treat HIV: How Can This Strategy be Improved? by da Silva, Laís Teodoro, Santillo, Bruna Tereso, de Almeida, Alexandre, Duarte, Alberto Jose da Silva, Oshiro, Telma Miyuki

    Published in Frontiers in immunology (18-12-2018)
    “…Harnessing dendritic cells (DC) to treat HIV infection is considered a key strategy to improve anti-HIV treatment and promote the discovery of functional or…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

    Phenotypic and functional profile of IFN-α-differentiated dendritic cells (IFN-DCs) from HIV-infected individuals by Santillo, Bruna Tereso, Reis, Denise da Silva, da Silva, Laís Teodoro, Romani, Nathalia Teixeira, Duarte, Alberto José da Silva, Oshiro, Telma Miyuki

    Published in Human vaccines & immunotherapeutics (02-09-2019)
    “…Dendritic cell (DC)-based immunotherapy is a promising strategy for the treatment of HIV-infected individuals. Different from the conventional protocol for DC…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10

    Characterization of monocyte-derived dendritic cells used in immunotherapy for HIV-1-infected individuals by da Silva, Laís Teodoro, da Silva, Wanessa Cardoso, de Almeida, Alexandre, da Silva Reis, Denise, Santillo, Bruna Tereso, Rigato, Paula Ordonhez, da Silva Duarte, Alberto José, Oshiro, Telma Miyuki

    Published in Immunotherapy (01-08-2018)
    “…A therapeutic vaccine based on monocyte-derived dendritic cells (MDDCs) has been shown to represent a promising strategy for the treatment of cancer and viral…”
    Get full text
    Journal Article
  11. 11

    Autologous and allogenic systems of HIV expansion: what is the better choice for clinical application in therapeutic vaccine? by Silva, Lais Teodoro da, Pontillo, Alessandra, da Silva, Wanessa Cardoso, Almeida, Alexandre de, Duarte, Alberto José da Silva, Oshiro, Telma Miyuki

    Published in Immunotherapy (01-12-2013)
    “…HIV-1 expanded in an allogenic system (Al-HIV) represents a cheaper and faster alternative to the autologous virus (Au-HIV) as an antigen in anti-HIV…”
    Get more information
    Journal Article
  12. 12
  13. 13
  14. 14